Search
Amylyx Pharmaceuticals Inc
AMLXAdd to Watchlist
32.410USD
-1.530-4.51%
Close 09-18 16:00（ET）
3.61BMarket Cap
LossP/E TTM
After-hours 17:43 (ET)32.540USD+0.150+0.46%
After-hours 17:43 (ET)TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D
Today
-4.51%
5 Days
+2.50%
1 Month
-7.69%
6 Months
+135.03%
Year to Date
+168.29%
1 Year
+144.60%
Key Figures
34.210Open
34.210High
73.62KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.07%Turnover Ratio
33.940Prev. Close
32.250Low
2.41MTurnover
LossP/E Static
15.10P/B
0.00%Div Yield TTM
-58.49%ROA
41.14052wk High
0.04Volume Ratio
-301.74MNet Profit
111.37MShares
-1.4849EPS TTM
-0.15Beta
-63.26%ROE
10.83052wk Low
5.36%Amplitude
63.22%Gross Margin
3.61BMarket Cap
6.07Reward/Risk
5.55%Risk Rate
Recent
Earnings
Amylyx Pharmaceuticals Inc's Score
0.12vs previous score
Forecast9.00
Financial Health5.42
Technical5.39
Valuation Dimensions8.93
Institutional Confidence10.00
Risk Assessment4.29
Media Coverage
Coverage Level
Very Low
Very High
Neutral
Analyst Rating
Amylyx Pharmaceuticals Inc Technical Analysis
Technical Indicators
Sell
Summary
Sell
Moving Average
Neutral
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
-0.39/-0.36
Revenue / Forecast
0.00/0.00
Amylyx Pharmaceuticals Inc Profile
SectorBiotechnology & Medical Research
Ticker SymbolAMLX
Number of employees123
CountryUnited States of America
Ownership
| Shareholders | Proportion |
|---|---|
| Fidelity Management & Research Company LLC | 13.43% |
| Perceptive Advisors LLC | 7.45% |
| BlackRock Institutional Trust Company, N.A. | 6.72% |
| TCG Crossover Management, LLC | 5.62% |
| Shareholder Types | Proportion |
|---|---|
| Investment Advisor | 42.93% |
| Hedge Fund | 22.94% |
| Investment Advisor/Hedge Fund | 21.26% |
| Individual Investor | 7.91% |
Related Instruments
+0.04%
-0.09%
-0.04%
-0.02%
-0.19%
-0.39%
+1.55%
-0.52%
+0.07%
+0.12%
+0.35%
-1.55%
-1.65%
-1.53%
-0.56%
-0.58%
-0.55%
-2.55%
-0.73%
-0.42%Popular Instruments
51734.000
-26.000 (-0.05%)
29664.700
+252.000 (+0.86%)
7659.100
+27.000 (+0.35%)
14420.000
+119.000 (+0.83%)
65079.000
+130.000 (+0.20%)
6230.800
-76.400 (-1.21%)
96.001
-1.985 (-2.03%)
336.130
-0.870 (-0.26%)
222.270
+2.930 (+1.34%)
4377.330
+36.350 (+0.84%)
FAQs
What is the current price of Amylyx Pharmaceuticals Inc (AMLX)?
The current price of Amylyx Pharmaceuticals Inc (AMLX) is 32.41.
What is the symbol of Amylyx Pharmaceuticals Inc?
The ticker symbol of Amylyx Pharmaceuticals Inc is AMLX.
What is the 52-week high of Amylyx Pharmaceuticals Inc?
The 52-week high of Amylyx Pharmaceuticals Inc is 41.14.
What is the 52-week low of Amylyx Pharmaceuticals Inc?
The 52-week low of Amylyx Pharmaceuticals Inc is 10.83.
What is the market capitalization of Amylyx Pharmaceuticals Inc?
The market capitalization of Amylyx Pharmaceuticals Inc is 3.61B.
Is Amylyx Pharmaceuticals Inc (AMLX) currently rated as Buy, Hold, or Sell?
According to analysts, Amylyx Pharmaceuticals Inc (AMLX) has an overall rating of STRONG BUY, with a price target of 42.36.
What is the Earnings Per Share (EPS TTM) of Amylyx Pharmaceuticals Inc (AMLX)?
The Earnings Per Share (EPS TTM) of Amylyx Pharmaceuticals Inc (AMLX) is -1.48.